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Abstract
Testicular germ cell tumor (TGCT) is the most common cancer in young men and is notable for its
high familial risks1,2. To date, six loci associated with TGCT have been reported3-7. From GWAS
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analysis of 307,291 SNPs in 986 cases and 4,946 controls, we selected for follow-up 694 SNPs,
which we genotyped in a further 1,064 TGCT cases and 10,082 controls from the UK. We
identified SNPs at nine new loci showing association with TGCT (P<5×10−8), at 1q22, 1q24.1,
3p24.3, 4q24, 5q31.1, 8q13.3, 16q12.1, 17q22 and 21q22.3, which together account for an
additional 4-6% of the familial risk of TGCT. The loci include genes plausibly related to TGCT
development. PRDM14, at 8q13.3, is essential for early germ cell specification8 whilst DAZL, at
3p24.3, is required for regulation of germ cell development9. Furthermore, PITX1, at 5q31.1
regulates TERT expression, and is the third TGCT locus implicated in telomerase regulation10.
Testicular germ cell tumor (TGCT) is the most common malignancy in men aged 15–45
years1. Studies in families have estimated the risk to brothers of TGCT cases to be increased
8- to 10- fold and to sons of cases 4- to 6-fold, and these risks are substantially higher than
the equivalent familial relatives risk of ~2 typical for common cancers such as breast,
colorectal and prostate2. Recent genome-wide association studies (GWAS) of TGCT have
identified eight associated SNPs at six loci, which together account for >11% of the genetic
risk of TGCT3-7. These loci lie on chromosome 12q21, encompassing KITLG, 5q31
(SPRY4), 6p21 (BAK1), 5p15 (TERT and CLPTM1L), 12p13 (ATF7IP) and 9p24
(DMRT1)11.
To identify further susceptibility loci for TGCT, we identified the most strongly associated
1,050 SNPs from our previous GWAS, which comprised 307,291 SNPs genotyped in 986
cases of TGCT and 4,946 controls from the UK3,4. These SNPs were included on a custom
Illumina iSelect genotyping array (the iCOGS array). The iCOGS array includes 211,155
cancer-related SNPs selected for further evaluation in different cancers and has already
yielded 80 new loci for breast, ovarian and prostate cancer12,13. Using the iCOGS array, we
genotyped 1,094 cases of TGCT from the UK, which had not been included in the original
GWAS. We compared these genotypes to those of three cancer-free UK control series, also
genotyped on the iCOGS array. Following quality control exclusions, we obtained data for
694 of the 1,050 SNPs in 1,064 cases and 10,082 controls (the ‘iCOGS replication series’).
We tested association between each SNP and TGCT risk using a 1df trend test, adjusted for
six principle components. Inflation in the test statistic, quantified using 36,879 uncorrelated
non-TGCT-related SNPs, revealed evidence of only modest inflation of the test statistics
(Supplementary Figure 1, λ=1.14, λ1000=1.07; following adjustment for six principle
components, λ=1.05, λ1000=1.02). There was clear evidence of association of the six
previously reported loci in the iCOGS replication series (Ptrend= 3.88×10−9 to 9.31×10−28),
with odds ratios consistent with those previously published (Supplementary Table 1).
In a combined fixed-effects meta-analysis of the GWAS and the adjusted iCOGS replication
for the remaining 640 SNPs outside of these six loci, we identified association of P<5×10−8
for a further 18 SNPs at nine loci: 1q22, 1q24.1, 3p24.3, 4q24, 5q31.1, 8q13.3, 16q12.1,
17q22 and 21q22.3. Following multiple logistic regression to test for independence of
effects, there remained one SNP at each of the nine loci showing association with TGCT
(Table 1). The associations at 1q24.1 and 17q22 have been replicated concurrently in other
independent TGCT series14,15.
For each SNP, we examined for evidence of departure from a log-additive (multiplicative)
model: only rs2072499 at 1q22 showed evidence for departure from the log-additive model,
indicating a recessive effect (heterozygote OR (ORhet): 1.00 (0.87-1.16), homozygote OR
(ORhom): 1.53 (1.27-1.84), P2df=5.18×10−6, Supplementary Table 2). This observation was
supported by genotypic (2df) analysis of the GWAS data for rs2072499 (ORhet 1.09
(0.94-1.26) ORhom 1.64 (1.24-2.01), P2df 1.25 ×10−6). We found no evidence for statistical
interaction between any pair of these new nine SNPs or with the previous eight SNPs; for
Ruark et al. Page 2
Nat Genet. Author manuscript; available in PMC 2013 December 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
every combination of SNPs, the combined risk was consistent with the product of the
individual risks.
We investigated whether the newly identified loci were associated with different risks in
subgroups of TGCT cases characterized by specific phenotypic characteristics
(Supplementary Tables 3,4,5). Consistent with our findings at the previous six loci, none of
the newly identified loci showed a significant difference in effect when comparing cases of
the two TGCT histological subtypes, seminoma and nonseminoma. Likewise, there was no
clear evidence of differential association by age of diagnosis, presence of testicular
maldescent, family history of TGCT or unilateral versus bilateral disease, although power to
detect differences in effects was limited on account of the case distribution.
Encyclopedia of DNA Elements (ENCODE) data indicated that rs2072499, rs3790672,
3805663, rs7010162, rs9905704 and rs2839186 may have effects on transcription on
account of evidence of location within a DNase I hypersensitivity site, local modification of
histones indicating promoter/enhancer activity, influence on binding of transcription factors
and/or effect on a regulatory motif. Functional annotations from the ENCODE data for all
correlated variants within each of the nine LD block (r2>0.8), are shown in Supplementary
Table 6. We then investigated whether the genotype at these nine SNPs was associated with
differential expression of genes lying within 500kB of the SNP: there were no compelling
patterns evident from expression data available from fibroblast, skin, adipose and
lymphoblastoid cells (Supplementary Table 7). Further examination in testicular germ cells
both for evidence of transcriptional regulation and of gene expression would be of interest.
Evidence supports TGCT developing from primordial germ cell or gonocytes, with tumor
initiation described in utero through a pre-invasive stage termed intra germ cell neoplasia
unclassified (IGCNU) or carcinoma in situ (CIS)16. It is therefore noteworthy that a number
of the genes identified at loci identified in this study relate to pathways of early
differentiation and development of the testicular germ cell11 (Table 1).
rs10510452 lies in an LD block of 82kb at 3p24.3 which contains only one gene, DAZL
(deleted in azoospermia-like). DAZL encodes an RNA-binding protein which has been
shown from expression studies in human primordial germ cells to have a central role in early
differentiation of primordial germ cells17. Dazl knockout mice are infertile, with
differentiation of the germ cells halted at the A spermatogonia level 9 and expression of
DAZL is testis-specific 18,19. Sequence analysis indicates that the DAZ cluster on the Y-
chromosome arose during primate evolution via transposition of the DAZL gene20. Of note,
DAZ has been implicated as the critical gene within the Y-chromosome AZF (azospermia
factor) region, so-named as deletions of this region cause non-obstructive spermatogenetic
failure (azoospermia) in humans21.
rs7010162 lies in an LD block of 61kb at 8q13.3 in which there is one gene, PRDM14,
which is required for both the reacquisition of potential pluripotency and the genomewide
epigenetic reprogramming necessary for primordial germ cell specification8,22,23. PRDM14
encodes a transcriptional regulator which controls expression of key pluripotency genes such
as POU5F1 (OCT4), NANOG and SOX2, which are highly expressed in IGCNU and
TGCT24,25. Whilst normal PRDM14 expression is restricted to germ cell and stem cell
lineages, amplification and/or over-expression of PRDM14 have been reported in a number
of different cancer types, including TGCT26-29.
rs3805663 is located in a 51kb LD block at 5q31.1 which contains two genes: CATSPER3
and PITX1. CATSPER3 (Cation-Channel, Sperm-associated 3) is one of a family of genes
which together form a functional hetero-tetrameric cation channel, exclusively expressed in
the testis and essential for hyperactivated motility of the differentiated germ cell
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(spermatozoa); accordingly Catsper3−/−male mice are completely infertile 30-32. An equally
plausible candidate gene at this locus is PITX1, (paired-like homeodomain transcription
factor 1), which binds to specific PITX1-binding sites in the promoter region of TERT, thus
regulating expression of telomerase10. Thus, along with the previously identified TGCT-
associated loci at 5p15 (TERT) and 12p13 (ATF7IP, which regulates expression of TERT),
the signal at 5q31.1 may also be mediated via effects on telomerase regulation. Whilst the
5p15 (TERT) region is notable for its associations with multiple cancers33-39, to date there
have been no associations reported with other cancers for the loci at 5q31.1 (PITX1) or
12p13 (ATF7IP).
rs9905704 lies at 17q22 in an LD block of 813kB in which there are several genes including
RAD51C and TEX14 (testis expressed 14). TEX14 is a protein kinase highly expressed in
the human male germ cell 40,41. Male Tex14 −/− mice are infertile whilst the female
knockouts are normally fertile42. Cellular studies have demonstrated that TEX14 regulates
kinetochoremicrotubule assembly and spindle assembly checkpoint in the germ cells of the
testis and requires recruitment of key proteins such CENPE, a kinesin-like motor protein
which associates with the centromere 41-43. It is thus noteworthy that CENPE (Centromere-
associated protein E) is located within the 214kb TGCT-associated LD block at 4q24.
Furthermore, PMF1, one of the two genes located in the TGCT-associated region at 1q22, is
part of the MIS12 complex which is required for normal chromosome alignment,
segregation and kinetochore formation during mitosis44. Therefore, regulation of
microtubule assembly may be the mechanism linking the signals at 17q22, 4q24 and 1q22.
In summary, we have identified nine new loci for TGCT, which brings the total number of
TGCT-associated loci identified to date to fifteen. These fifteen loci have provided
considerable new insights into TGC tumourigenesis, implicating genes involved in germ cell
specification and/or differentiation (DAZL, PRDM14) including the KIT-KITL signalling
pathway (KITL, SPRY4, BAK1) and genes involved in sex-determination (DMRT1),
microtubule assembly (TEX14, CENPE, PMF1) and telomerase regulation (TERT, ATF7IP,
PITX1). The nine new susceptibility alleles account for ~4% of the excess familial risk to
brothers and ~6% to sons of men with TGCT: this brings the cumulative totals to ~15% and
~22% respectively. The power to detect these loci in this combined analysis was modest
(29-84%): accordingly there are likely to be several additional loci for TGCT of equivalent
or lesser effects, which may be identifiable via still larger follow-up studies of these data
and meta-analyses with other GWAS data. Moreover, imputation and fine-scale association
mapping of the loci may uncover more of the missing heritability, either through identifying
more strongly associated variants or by identifying additional signals, including rare
variants, at these loci. Integration of these genetic variants together with non-genetic TGCT
risk factors into risk models may enable clinically useful risk profiling for TGCT in
unaffected men; which in turn may provide a rational basis for application of strategies for
screening and targeted prevention of TGCT.
Methods
Samples
See Supplementary Note
GWAS analysis
Cases were genotyped on the Illumina HumanCNV370-Duo bead array and controls were
genotyped on the Illumina Infinium 1.2M array at the Wellcome Trust Sanger Institute (see 3
and 4 for full methods). The genotypes were re-called since the analysis reported in 4, such
that SNPs on both sex chromosomes were included in the current analysis. We used data on
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314,861 SNPs that were successfully genotyped on both arrays. We excluded individuals:
with low call rate (<95%), with abnormal autosomal heterozygosity or with >10% non-
European ancestry (based on multi-dimensional scaling). We filtered out all SNPs with (i)
minor allele frequency <1%, (ii) a call rate of <95% in cases or controls or (iii) minor allele
frequency of 1–5% and a call rate of <99% or (iv) deviation from Hardy-Weinberg
equilibrium (10−12 in controls and 10−5 in cases). 307,291 SNPs passed the QC filters and
we put forward for replication the 1050 SNPs with the lowest P-value (P<1.3 × 10−3), based
on the 1-d.f. Cochran-Armitage trend test.
iCOGS Genotyping
Genotyping was conducted using a custom Illumina Infinium array (iCOGS array)
comprising 211,155 SNPs selected across multiple consortia within the COGS
(Collaborative Oncological Gene-environment Study, see 12 for details of SNP inclusion).
Of the 1,050 SNPs submitted from our analysis, 740 attained an Illumina design score of
≥0.8, and were included on the array. Genotyping was performed at Genome Quebec, one of
the seven genotyping centres providing genotyping for the COGS collaboration. Genotypes
were called using Illumina’s proprietary GenCall algorithm. Pan-COGS initiatives were
employed across experiments to optimize calling algorithms for the iCOGS array: firstly,
initial calling employed a cluster file generated using samples from Hapmap2; secondly, a
cluster file based on 3,018 individuals selected across genotyping centers, across
participating consortia and across ethnicities, combined with 380 samples of European,
Asian or African ancestry genotyped as part of the Hapmap and 1000 genomes project was
applied to call the genotypes for the subsequent samples. Thirdly, the performance of
GenCall was compared to two other calling algorithms: Illuminus54 and GenoSNP55: all
three algorithms were >99% concordant in their calling for 91% of the SNPs on the array.
Manual inspection of a sample of the discrepant SNPs indicated that the GenCall calls were
almost invariably superior (because Illuminus and GenoSNP frequently attempted to call
SNPs that clustered poorly) 12.
Quality Control
Using the full SNP set of 211,155 SNPs on the iCOGS array, we applied quality control
exclusions as follows to subjects: i) subjects with overall call rate <95% or low or high
heterozygosity (P<10−6) (5 cases), ii) using identity-by-state estimates based on 37,046
uncorrelated SNPs, we identified “cryptic” duplicates and related samples and the sample
with the lower call rate was excluded (7 cases), iii) we identified ethnic outliers by multi-
dimensional scaling by combining the iCOGS data with the three Hapmap2 populations
using 37,046 uncorrelated markers and removed individuals with >10% non-Western
European ancestry (18 cases). We included 1,064 cases and 10,082 controls in the final
analysis.
We applied quality control exclusions as follows to SNPs: i) discrepant calls in more than
2% of duplicate samples across COGS consortia, ii) call rate <95%, MAF<1%, call rate
<99% if MAF=1-5%, iii) deviation from Hardy-Weinberg (P<10−5 in controls, P<10−12 in
cases ). Following quality control exclusions applied individually to case and control data,
we included genotypes from 694 SNPs in subsequent analyses. We checked genotype
intensity cluster plots manually for SNPs in each new region for which a genome-wide
significant association was achieved.
Statistical Analysis
For the 694 SNPs in the TGCT iCOGS replication experiment, we estimated the per-allele
odds ratio (OR), 1df, using logistic regression, adjusting for principal components as
covariates. We generated eight principle components and examined reduction in the
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inflation factor using iterative combinations of principle components. Inclusion of principle
components 1-6 achieved optimal reduction in inflation with no further reduction achieved
by incorporating additional principle components into the regression model. We found no
significant differences in the point estimates of effect size on performing sensitivity analysis
between the control groups used in the TGCT iCOGS replication experiment.
The inflation factor (λ) was derived by dividing the median of the lowest 90% of the 1-d.f.
statistics by the 45% percentile of a 1-d.f. χ2 distribution (0.357), utilizing 36,879
uncorrelated SNPs selected to not include TGCT-associated SNPs. The inflation was
converted to an equivalent inflation for a study with 1000 cases and 1000 controls (λ1,000):
We excluded from further analysis the 54 SNPs lying within the six previously identified
TGCT-associated loci, defining these LD blocks via the Oxford recombination rates. We
included the 640 remaining SNPs in the replication analysis.
Because the inflation factor in the GWAS data had been modest (λ = 1.078, λ1000 = 1.045),
we did not adjust the analysis of the GWAS data. We obtained overall significance levels by
combining the estimates from the GWAS (unadjusted) and the iCOGS replication (adjusted
for principle components 1-6) using a fixed effects meta-analysis, to derive a 1df test,
calculating an I2 statistic to evaluate heterogeneity between the GWAS and replication. We
used a threshold of 5×10−8 to denote genome-wide significance. Of note we had previously
examined the loci at 1q24.1 and 4q24 in our first GWAS replication experiment3: whilst
there had been evidence of replication of these signals via Taqman genotyping of 565 cases
and 1,758 controls, these associations had failed to achieve genome-wide significance.
We also computed genotype-specific ORs (2 df) for the iCOGS replication, adjusted for
principle components 1-6 (Supplementary Table 2). We assessed each SNP for dose
response (Phetergeneity) in the replication series by comparing 1-d.f. and 2-d.f. logistic
regression models,both adjusted for principle components 1-6, using a likelihood ratio test
(evaluated using a significance threshold of Phetergeneity < 0.006 to account for 9 tests). We
examined for statistical interaction between TGCT predisposition SNPs (nine new SNPs and
the previously published eight SNPs) by evaluating the effect of adding an interaction term
to the regression model, adjusted for stage, using a likelihood ratio test (using a significance
threshold of P < 0.0003 to account for 144 tests).
We assessed for modification of the odds ratios by covariate phenotype and risk factors
using a case-only analysis incorporating both GWAS and iCOGS replication data
(unadjusted). We evaluated the effect of age on SNP genotype via polytomous regression:
we divided age at diagnosis into 5 ordinal categories and fitted maximum-likelihood
multinomial logistic models, executed using the mlogit command in Stata12 (using a
significance threshold of P < 0.006 to account for 9 tests, Supplementary Tables 3, 4, 5).
We identified variants from within each LD block reported within the 1000 genomes project
(r2>0.8 and <200kB from sentinel SNP) and used HaploReg and ENCODE data to apply
functional annotations relevant to the regulation of transcription: (i) whether the variant lies
in a region in which modification of histone proteins is suggestive of enhancer and other
regulatory activity (H3K4Me1 and H3K27A histone modification) or promoter activity
(H3K4Me3 histone modification), (ii) whether the variant lies in a region where the
chromatin is hypersensitive to cutting by the DNase enzyme (suggestive of regulatory
region), (iii) whether the variant lies in a region of binding of transcription factor proteins
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(as assayed by chromatin immunoprecipitation with antibodies specific to the transcription
factor followed by sequencing of the precipitated DNA (ChIP-seq)), (iv) whether the variant
affects a specific regulatory motif, as evaluated from position weighted matrices assembled
from TRANSFAC, JASPAR and protein-binding microarray experiments (Supplementary
Table 6)45,46.
We investigated associations of the nine TGCT-associated SNPs with gene expression using
GENEVAR, which includes gene expression profiling and genotypic data from four
datasets: (i) lymphoblastoid cell lines (LCL) from 726 HapMap individuals adipose
(HapMap3), (ii) LCL and skin collected from 856 healthy female twins of the MuTHER
resource (Muther pilot Twin 1), (iii) adipose, LCL and skin derived from a subset of 160
MuTHER healthy female twins (Muther pilotTwin2) and (iv) fibroblast, LCL and T-cells
derived from umbilical cords of 75 Geneva GenCord individuals (Gencord). Spearman Rank
Correlation between normalized gene expression levels and the count of one of the alleles of
the SNP (0, 1 or 2) was analysed with significance assessed by permutation (10,000
permutations). Expression of genes within 500kB of the sentinel SNP was examined (using
a significance threshold of P < 0.00001 to account for 440 tests, Supplementary Table 7).
LD matrices between SNPs reported in HapMap were based on Data Release 27/phaseII +
III (Feb 2009) on NCBI B36 assembly, dbSNP b126, viewed using Haploview software
(v4.2) and plotted using SNAP. LD blocks were evaluated using the HapMap recombination
rates (cM/Mb) and defined using the Oxford recombination hotspots47. GWAS associations
for other diseases were evaluated using the NHGRI (National Human Genome Research
Institute) Catalog of Published Genome-Wide Association Studies. All genomic references
are based on NCBI Build 36. Analyses were performed using R (v2.6), Stata12 (State
College) and PLINK (v1.07) software.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Regional plots of the nine new TGCT loci (a–i)
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Plots show the genomic regions of association with TGCT on chromosome (a), 1q22 (b)
1q24.1, (c) 3p24.3, (d) 4q24, (e) 5q31.1, (f) 8q13.3, (g) 16q12.1, (h) 17q22 and (i) 21q22.3.
Shown by diamonds are the −log10 association P values of SNPs in 986 cases and 4,946
controls from the GWAS, combined with 1,064 cases of TGCT and 10,082 controls from the
iCOGs replication. Shown by squares are SNPs genotyped in the GWAS alone. The
intensity of red shading indicates the strength of LD with the index SNP (labeled). Also
shown are the SNP build 36 coordinates in kilobases (kb), recombination rates in
centimorgans (cM) per megabase (Mb) (in blue) and the genes in the region (in green).
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Table 1
Summary results for nine SNPs showing genome-wide association (P<5×10−8) in the combined analysis.
SNP1 Location2 Alleles3 RAF4
GWAS iCOGS replication Combined
OR5
(95% CI) Ptrend
6 adjusted OR7
(95% CI) Ptrend
6 Pmeta8
rs2072499 154,436,2341q22 G/A 0.35
1.24
(1.12-1.37) 1.84×10−5
1.19
(1.08-1.3) 2.98×10−4 2.57×10−8
rs3790672 164,140,0161q24.1 C/T 0.28
1.26
(1.14-1.4) 1.10×10−5
1.20
(1.09-1.33) 2.92×10−4 1.59×10−8
rs10510452 16,600,0523p24.3 A/G 0.69
1.24
(1.12-1.39) 7.06×10−5
1.24
(1.12-1.37) 4.69×10−5 1.28×10−8
rs2720460 104,274,1354q24 A/G 0.61
1.28
(1.16-1.42) 2.25×10−6
1.24
(1.12-1.36) 1.97×10−5 2.18×10−10
rs3805663 134,394,0995q31.1 T/C 0.63
1.20
(1.08-1.33) 4.86×10−4
1.25
(1.13-1.38) 7.14×10−6 1.56×10−8
rs7010162 71,139,0598q13.3 G/A 0.61
1.21
(1.09-1.34) 2.03×10−4
1.22
(1.11-1.34) 6.05×10−5 4.60×10−8
rs8046148 48,700,44516q12.1 G/A 0.79
1.29
(1.13-1.46) 1.03×10−4
1.32
(1.17-1.48) 8.75×10−6 3.68×10−9
rs9905704 53,987,54217q22 T/G 0.67
1.29
(1.16-1.43) 3.74×10−6
1.21
(1.1-1.34) 1.50×10−4 3.06×10−9
rs2839186 46,514,49621q22.3 T/C 0.46
1.20
(1.09-1.32) 3.01×10−4
1.26
(1.15-1.38) 7.43×10−7 1.18×10−9
1dbSNP rs number
2
Build 36 position, chromosomal region
3
Risk/non-risk associated alleles.
4
RAF:Frequency of the risk allele
5OR: per allele odds ratio
6
Ptrend: p-value for trend, via logistic regression
7Adjusted OR: per allele odds ratio, adjusted for six principle components
8
Pmeta: P-value for fixed effects meta-analysis
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